Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access graft-versus-host disease specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related graft-versus-host disease treatment provided free
This phase II trial tests how well axatilimab works in treating patients with thickening or hardening (sclerosis) of the skin related to chronic graft-versus-host disease after a donor stem cell transplant. Chronic graft-versus-host disease (cGVHD) remains a major complication of donor stem cell transplants. Sclerosis, while not associated with a higher risk of death, can lead to serious disabilities. Usual treatments for cGVHD can be associated with significant side effects and unsatisfactory o
Sponsor: Fred Hutchinson Cancer Center
Check if you qualify for this graft-versus-host disease clinical trial in Seattle, WA
If you're searching for graft-versus-host disease treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.